Glycine (Glycine)

Trade Name : Glycine

B. Braun Medical Inc.

IRRIGANT

Strength 1.5 g/100mL

GLYCINE

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Glycine (Glycine) which is also known as Glycine and Manufactured by B. Braun Medical Inc.. It is available in strength of 1.5 g/100mL per ml. Read more

Glycine (Glycine) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • Each 100 mL contains:
  • Glycine USP ..................................................................................... 1.5 g Water for Injection USP ................................................................... u00a0u00a0u00a0u00a0qs
  • pH: 6.1 (4.5-6.5) Calculated Osmolarity: 200 mOsmol/liter
  • The formula of the active ingredient is:
  • 1.5% Glycine Irrigation USP is a sterile, nonpyrogenic aqueous solution suitable for urologic irrigation. This solution is slightly hypotonic.
  • The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers and exhibits virtually no leachables. The solution contact layer is a rubberized copolymer of ethylene and propylene. The container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.
  • Not made with natural rubber latex, PVC or DEHP.
  • 1.5% Glycine Irrigation USP is nontoxic and nonhemolytic with a refractive index close to that of water. These properties make it useful as a urologic irrigating fluid, particularly during transurethral surgical procedures where the irrigant may be absorbed through cut venous sinuses.
  • Systemically absorbed glycine is primarily metabolized by transamination to serine, and by deamination to ammonia which is normally removed by its conversion to urea. A portion of the absorbed glycine is excreted by the kidneys.
  • 1.5% Glycine Irrigation USP is indicated as an irrigant during transurethral prostatic or bladder surgery.
  • 1.5% Glycine Irrigation USP is not for injection. It is contraindicated in patients with anuria.
  • Solutions for urologic irrigation must be used with caution in patients with severe cardiopulmonary or renal dysfunction.
  • The amount of fluid absorbed during a transurethral resection is a function of the volume and hydrostatic pressure of the irrigant used, the number and size of venous sinuses opened, and the duration of the procedure. Since irrigating fluids used during transurethral prostatectomy have been demonstrated to enter the systemic circulation in relatively large volumes, any irrigation solution must be regarded as a systemic drug.
  • Absorption of large amounts of fluids containing glycine and the resultant osmotic diuresis may significantly affect cardiopulmonary and renal dynamics. Absorption of large amounts of irrigating solution can also result in pronounced hyponatremia and water intoxication.
  • After opening container, the contents should be used promptly to minimize the possibility of bacterial growth or pyrogen formation.
  • Discard unused portion of irrigating solution since it contains no preservative.
  • Cardiovascular status, especially in patients with cardiac disease, should be carefully determined before and during transurethral resection of the prostate when using 1.5% Glycine Irrigation USP as an irrigant. The fluid absorbed into the systemic circulation via severed prostatic veins may produce significant extracellular fluid expansion and lead to fulminating congestive heart failure.
  • Shift of sodium-free intracellular fluid into the extracellular compartment following systemic absorption of 1.5% Glycine Irrigation USP may lower serum sodium concentration and aggravate pre-existing hyponatremia.
  • Excessive loss of water and electrolytes may lead to serious imbalances. Sustained diuresis from transurethral irrigation with 1.5% Glycine Irrigation USP may obscure and intensify inadequate hydration or hypovolemia.
  • Care should be exercised if impaired liver function is known or suspected. Under such conditions, ammonia resulting from the metabolism of glycine may accumulate in the blood.
  • Use only if solution is clear and container and seal are intact.
  • Adverse reactions may include fluid and electrolyte disorders such as acidosis, electrolyte loss, marked diuresis, urinary retention, edema and dehydration; cardiovascular/pulmonary disorders such as pulmonary congestion, hypotension, tachycardia, angina-like pain and thrombophlebitis; other possible reactions include visual disturbances, convulsions, nausea, vomiting, diarrhea, vertigo and urticaria.
  • Literature includes reports on hyponatremia, hyperammonemia, transient blindness, coma (immediate or delayed), and digitalis toxicity in digitalized patients.
  • If an adverse reaction occurs, discontinue the irrigant and reevaluate the clinical status of the patient.
  • As required for irrigation.
  • 1.5% Glycine Irrigation USP should be administered only by the appropriate transurethraI urologic instrumentation.
  • It has been reported that absorption is significantly increased if the container is higher than 60 cm (24 inches) above the patient.
  • This drug product should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
  • 1.5% Glycine Irrigation USP is supplied sterile and nonpyrogenic in single-dose 3000 mL flexible irrigation containers packaged 4 per case.
  • Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25u00b0C); however, brief exposure up to 40u00b0C does not adversely affect the product.
  • Do not warm container over 150u00b0F (66u00b0C).
  • Rx only
  • Revised:u00a0October 2015
  • For Irrigation Use Only.
  • Not for injection.
  • Not for use with pressurized irrigation systems or powered irrigation devices.
  • Aseptic technique is required.
  • 1.u00a0u00a0u00a0u00a0u00a0To open: Tear overwrap starting from the tear notches. (Figure 1)
  • 2. u00a0u00a0u00a0 Prepare medication port by removal of aluminum foil. (Figure 2a)
  • 3.u00a0u00a0u00a0u00a0u00a0u00a0Remove aluminum foil from outlet/set port at the bottom of container (Figure 4a) and attach administration set (Figure 4b): use non-vented infusion set or close air vent on a vented set. Refer to directions for use accompanying the administration set.
  • 4.u00a0u00a0u00a0u00a0u00a0u00a0u00a0 Hang bag on IV Pole. (Figure 5)
  • B. Braun Medical Inc.
  • Y36-002-909u00a0u00a0 LD-412-4
  • 1.5% Glycine Irrigation USP
  • For Urologic Irrigation
  • REF R8406NDC 0264-7390-60n n- LOTEXP.
  • 3000 mL
  • Each 100 mL contains: Glycine USP 1.5 g Water for Injection USP qs
  • pH: 6.1 (4.5-6.5)
  • Calc. Osmolarity: 200 mOsmol/liter
  • Not for Injection.
  • Use only if solution is clear and container and seal are intact.
  • Warning:
  • Sterile, nonpyrogenic. Single unit container. Discard unused portion. Use aseptic technique.
  • Recommended Storage: Room temperature (25u00b0C).Avoid excessive heat. Protect from freezing.Do not remove overwrap until ready for use. See Package Insert.
  • Not made with natural rubber latex, PVC or DEHP.u00a0 u00a0u00a0
  • Rx only
  • Arrayn- Array
  • u00a0
  • u00a0
  • u00a0
  • SET
  • u00a0n- Array
  • B. Braun Medical Inc. n
  • Y38-000-045u00a0u00a0u00a0u00a0 LD-257-5

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.